QurieGen
QurieGen speeds up drug discovery by revealing how cells respond to drug candidates and predicting downstream effects. The company combines a proprietary method for mapping cellular signaling responses with AI models that predict responses to drug perturbations. It operates as a biotech platform focused on drug discovery R&D workflows and serves pharmaceutical and biotechnology teams. Core technologies include cellular response mapping and machine learning prediction models integrated into early-stage drug discovery pipelines. QurieGen targets the drug discovery market by providing data-driven insights that can replace multiple incompatible analytical tools.
QurieGen
QurieGen speeds up drug discovery by revealing how cells respond to drug candidates and predicting downstream effects. The company combines a proprietary method for mapping cellular signaling responses with AI models that predict responses to drug perturbations. It operates as a biotech platform focused on drug discovery R&D workflows and serves pharmaceutical and biotechnology teams. Core technologies include cellular response mapping and machine learning prediction models integrated into early-stage drug discovery pipelines. QurieGen targets the drug discovery market by providing data-driven insights that can replace multiple incompatible analytical tools.